Merck’s colorectal cancer therapy fails late-stage trial
Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed… Read More
2 months ago
Merck
Merck raises 2024 profit forecast on cancer drug sales
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back… Read More
7 months ago
Merck says multiple sclerosis drug has blockbuster potential
The CEO of Germany's Merck KGaA said the company's experimental multiple sclerosis drug can be… Read More
1 year ago
Prevymis: Merck’s viral infection drug gets EU recommendation
Merck & Co said on Tuesday the European Union medicines regulator recommended a marketing authorisation… Read More
1 year ago
Molnupiravir: China grants conditional approval for COVID treatment
China has granted conditional approval for the import of Merck's COVID-19 treatment Molnupiravir, China's medical… Read More
2 years ago
WHO recommends Merck’s COVID pill for high-risk patients
A World Health Organization (WHO) panel on Wednesday backed the use of molnupiravir- Merck &… Read More
3 years ago
UK to begin testing Merck’s COVID pill for hospitalised patients
UK scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible… Read More
3 years ago
Cheap version of Merck COVID pill to be made for poorer nations
A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost… Read More
3 years ago
Drugmaker to launch generic COVID-19 Merck drug at about Rs70
Indian drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19… Read More
3 years ago
Belgium to buy 10,000 courses each of Pfizer and Merck COVID-19 pills
Belgium will buy 10,000 courses each of the COVID-19 pills developed by Pfizer and Merck,… Read More
3 years ago
Japan health panel approves Merck’s oral COVID-19 treatment
A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed… Read More
3 years ago
US regulator authorizes Merck’s Covid pill
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high… Read More
3 years ago
France cancels order for Merck’s COVID-19 antiviral drug
France has cancelled its order for Merck's COVID-19 antiviral drug following disappointing trial data and… Read More
3 years ago
Merck Covid pill backed for EU emergency use
The EU's drug watchdog on Friday backed Merck's anti-Covid pill for emergency use ahead of… Read More
3 years ago
Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted
Indonesia is reviewing a COVID-19 experimental antiviral pill- molnupiravir- produced by Merck for domestic use,… Read More
3 years ago
How does Merck’s COVID-19 pill compare to Pfizer’s?
Pfizer and Merck have developed experimental antiviral pills that have shown promising efficacy in trials… Read More
3 years ago
Britain approves Merck’s COVID-19 pill in world first
Britain on Thursday became the first country in the world to approve a potentially game-changing… Read More
3 years ago
Molnupiravir: Countries rush to buy Merck experimental COVID-19 pill
Merck has signed eight deals to sell more than a total of 2 million courses… Read More
3 years ago
Merck signs pact to allow more companies to manufacture COVID-19 pill
Merck has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that… Read More
3 years ago
Molnupiravir: Heres’ what you need to know about Merck’s COVID-19 pill
As Merck and partner Ridgeback Biotherapeutics announced earlier this month that their pill Molnupiravir was… Read More
3 years ago